Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 25,000 shares at $47.00 ($1.2M) on 2018-06-29, disclosed to the SEC on 2018-07-03.
Seasonal sale ($1.2M) by SVP, CFO and Treasurer — this insider has traded XLRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.00 | 12,500 | $588K | 49.0% |
| 2 | $49.00 | 12,500 | $613K | 51.0% |
| Total | $48.00 avg | 25,000 | $1.2M | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |